Artificial intelligence is not yet able to fully replace human experts in important drug safety work, FDA cautions.
Key Takeaways
-
Causality assessments for adverse events still require human expertise and judgement, US FDA officials say. Pharma should keep this in mind as it explores...
The pharmaceutical industry is exploring the application of AI to the processing of individual case safety reports (ICSR), Center for Drug Evaluation and Research Deputy Director in the Office of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?